SCHEMBL29464458

SCHEMBL29464458

Cc1ccc(F)cc1-c1nc(NS(=O)(=O)c2cccc(N3CCC(C)(C(=O)O)CC3)n2)ccc1Cl

nearest known ligand 0.34

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 9/20 0.34
SMO Q99835 1/20 0.34
KIF18A Q8NI77 3/20 0.33
RORC P51449 1/20 0.33
AURKA O14965 1/20 0.32
AURKB Q96GD4 1/20 0.32
ALDH1A1 P00352 1/20 0.32
PTPN11 Q06124 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
DGAT1 O75907 1/20 0.32
KCNH2 Q12809 1/20 0.32
CTSA P10619 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19951361 1.00 ABL1 (0.34) ABL1SMOKIF18ARORCAURKA
SCHEMBL19927752 0.92 PTPN11 (0.36) KIF18ARORCALDH1A1PTPN11MEN1
SCHEMBL19925055 0.90 ABL1 (0.33) ABL1SMOKIF18AALDH1A1CTSA
SCHEMBL19925143 0.90 SMO (0.34) SMOKIF18ARORCPTPN11MEN1
SCHEMBL19925185 0.89 RORC (0.35) ABL1KIF18ARORC
SCHEMBL29464968 0.89 RORC (0.35) ABL1KIF18ARORC
SCHEMBL23748045 0.88 ALDH1A1 (0.38) ABL1SMOALDH1A1KMT2ACTSA
SCHEMBL19951393 0.87 RORC (0.37) ABL1KIF18ARORCAURKAAURKB
SCHEMBL19927722 0.86 RORC (0.37) KIF18ARORCAURKAAURKBPTPN11
SCHEMBL19925624 0.86 MEN1 (0.38) KIF18ARORCPTPN11MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109641873-B N- (pyridin-2-yl) pyridine-sulfonamide derivatives and their use for the treatment of disease 诺华股份有限公司 2022-03-18 CN claimed
CN-109641873-B N- (pyridin-2-yl) pyridine-sulfonamide derivatives and their use for the treatment of disease 诺华股份有限公司 2022-03-18 CN disclosed